Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis.
Saved in:
| Title: | Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis. |
|---|---|
| Authors: | Sugiyama N; Rheumatology, Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Terry FE; EpiVax, Inc., Providence, RI, United States., Gutierrez AH; EpiVax, Inc., Providence, RI, United States., Hirano T; Rheumatology, Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Hoshi M; Rheumatology, Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Mizuno Y; Rheumatology, Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan., Martin W; EpiVax, Inc., Providence, RI, United States., Yasunaga S; Department of Biochemistry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan., Niiro H; Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan., Fujio K; Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., De Groot AS; EpiVax, Inc., Providence, RI, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2024 May 15; Vol. 15, pp. 1377911. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
